ArticleJournal of managed care & specialty pharmacy2023

The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review's Midwest Public Advisory Council.

Abigail C Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.